Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 2
Total trials 2

My Organizations' Clinical Trials

Showing 475 of 1074 entries
View as:

Development and Feasibility Testing of a Mobile Phone-Based HIV Primary Care Engagement Intervention

Phase: N/A Priority: Normal
NCT ID: NCT02468544 Org: User:
Start: 03/31/17 End: 04/30/17 Due: 04/30/18

Topical Vancomycin for Neurosurgery Wound Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT02284126 Org: User:
Start: 10/31/14 End: 06/30/21 Due: 06/30/22

Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT00859469 Org: User:
Start: 04/30/04 End: 03/31/13 Due: 03/31/14

Swaziland HIV Incidence Measurement Survey 2

Phase: N/A Priority: Normal
NCT ID: NCT04117984 Org: User:
Start: 08/30/16 End: 12/31/19 Due: 12/31/20

Motivational Interviewing for Getting Healthy TodaY Study

Phase: N/A Priority: Normal
NCT ID: NCT03410225 Org: User:
Start: 06/01/19 End: 08/28/19 Due: 08/28/20

Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®

Phase: N/A Priority: Normal
NCT ID: NCT00710606 Org: User:
Start: 06/30/08 End: 12/31/08 Due: 12/31/09

Mental Health Support for Transgender and Gender-expansive Individuals

Phase: N/A Priority: Normal
NCT ID: NCT06229132 Org: User:
Start: 03/15/22 End: 06/30/23 Due: 06/30/24

Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT03287830 Org: User:
Start: 10/06/17 End: 04/30/19 Due: 04/30/20

COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry

Phase: N/A Priority: Normal
NCT ID: NCT04661657 Org: User:
Start: 12/28/20 End: 01/22/22 Due: 01/22/23

Anesthesia and Postoperative Pain

Phase: N/A Priority: Normal
NCT ID: NCT00232817 Org: User:
Start: 07/31/03 End: 03/31/06 Due: 03/31/07

Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders

Phase: N/A Priority: Normal
NCT ID: NCT03723694 Org: User:
Start: 01/01/19 End: 06/26/23 Due: 06/26/24

Self-Distancing for Specific Phobia in Youth

Phase: N/A Priority: Normal
NCT ID: NCT06339463 Org: User:
Start: 10/31/26 End: 10/31/28 Due: 10/31/29

Blue Blockers at Night and Insomnia Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT02698800 Org: User:
Start: 03/31/16 End: 03/31/17 Due: 03/31/18

FUS Etoposide for DMG

Phase: N/A Priority: Normal
NCT ID: NCT05762419 Org: User:
Start: 06/05/23 End: 12/31/27 Due: 12/31/28

Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality

Phase: N/A Priority: Normal
NCT ID: NCT02889133 Org: User:
Start: 01/31/17 End: 10/05/21 Due: 10/05/22

Study of the Implementation of Telehealth-Supported LARC Provision in School-Based Health Centers

Phase: N/A Priority: Normal
NCT ID: NCT04840836 Org: User:
Start: 04/20/21 End: 12/31/22 Due: 12/31/23

Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00998036 Org: User:
Start: 09/30/09 End: 10/31/12 Due: 10/31/13

Smoking Cessation Pilot for People Living With HIV (PLWH)

Phase: N/A Priority: Normal
NCT ID: NCT04808609 Org: User:
Start: 10/06/20 End: 07/16/21 Due: 07/16/22

Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00691210 Org: User:
Start: 06/30/08 End: 03/31/15 Due: 03/31/16

Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods

Phase: N/A Priority: Normal
NCT ID: NCT04703790 Org: User:
Start: 04/07/21 End: 02/18/22 Due: 02/18/23

Renal Artery Dopplers in Twin Twin Transfusion Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03449823 Org: User:
Start: 09/09/16 End: 06/30/18 Due: 06/30/19

Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT01611571 Org: User:
Start: 12/31/03 End: 11/30/11 Due: 11/30/12

Mother Infant Retention for Health: MIR4Health

Phase: N/A Priority: Normal
NCT ID: NCT01962220 Org: User:
Start: 03/31/13 End: 06/30/15 Due: 06/30/16

Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)

Phase: N/A Priority: Normal
NCT ID: NCT06889168 Org: User:
Start: 07/01/25 End: 11/30/26 Due: 11/30/27

Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT03182738 Org: User:
Start: 11/16/16 End: 05/31/19 Due: 05/31/20